Caribou Biosciences, Inc. (CRBU) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Caribou Biosciences, Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBU
Caribou Biosciences, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LENZ
LENZ Therapeutics, Inc.
$3.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRBU vs LENZ
growth of $100 · dividends reinvested · last 5yCRBU -92.7% (-40.8%/yr)LENZ -93.6% (-42.3%/yr)CRBU compounded faster over this window
CRBU LENZ
CRBU vs LENZ: by the numbers
- •LENZ is the larger company ($119M vs $113M market cap).
- •Both run net losses; LENZ's is the smaller (-586.74% vs -1030.42% net margin).
Metrics side by side
Valuation
| Metric | CRBU | LENZ |
|---|---|---|
| P/S ratio | 11.22 | 5.53 |
| P/B ratio | 1.15 | 0.54 |
Profitability
| Metric | CRBU | LENZ |
|---|---|---|
| Gross margin | 67.34% | 90.14% |
| Operating margin | -1220.49% | -477.46% |
| Net margin | -1030.42% | -586.74% |
| ROE | -105.40% | -57.47% |
| ROIC | -87.72% | -61.84% |
Growth (annualized)
| Metric | CRBU | LENZ |
|---|---|---|
| Revenue CAGR (5Y) | -2.03% | N/A |
| Total return CAGR (5Y) | -44.43% | -35.49% |
Frequently asked
- How have CRBU and LENZ total returns compared?
- Over the past 5 years, CRBU delivered -44.43% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.